Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease-Reference-Cited by-同舟云学术

Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease

Published:2009-09-09 Issue:2 Volume:51 Page:454-462
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Wong Vincent Wai-Sun,Vergniol Julien,Wong Grace Lai-Hung,Foucher Juliette,Chan Henry Lik-Yuen,Le Bail Brigitte,Choi Paul Cheung-Lung,Kowo Mathurin,Chan Anthony Wing-Hung,Merrouche Wassil,Sung Joseph Jao-Yiu,de Lédinghen Victor

Publisher

Wiley

Subject

Hepatology

Reference33 articles.

1. Diagnosis and therapy of nonalcoholic steatohepatitis;Torres;Gastroenterology,2008

2. Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease;Wong;Clin Gastroenterol Hepatol,2006

3. Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease;Wong;Aliment Pharmacol Ther,2006

4. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma;Bugianesi;Gastroenterology,2002

5. Histological progression of non-alcoholic fatty liver disease in Chinese patients;Hui;Aliment Pharmacol Ther,2005

Cited by 1084 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Helicobacter pylori cagA/vacAs1-m1 strain is associated with high risk of fibrosis in metabolic-dysfunction-associated steatotic liver disease;Annals of Hepatology;2024-11

2. Dynamic Changes in ELF Score Predict Hepatocellular Carcinoma in Chronic Hepatitis B Patients Receiving Antiviral Treatment;Journal of Viral Hepatitis;2024-09-10

3. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD);Journal of Hepatology;2024-09

4. The Impact of Japanese Dietary Patterns on Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis;Nutrients;2024-08-28

5. Gut phageome in Mexican Americans: a population at high risk for metabolic dysfunction-associated steatotic liver disease and diabetes;mSystems;2024-08-21